Sign in

CIK 0001157601

  • Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Grant or award President and CEO acquired 11,549 shares (grant or award)
  2. 4 Open-market sale SVP, Chief Medical Officer sold 2,617 shares at $5.32 ($13,928)
  3. 4 Open-market sale VP, IP and Legal, Gen. Counsel sold 5,284 shares at $5.25 ($27,762)
  4. 4 Open-market sale VP, Fin. and Admin., CFO sold 2,537 shares at $5.51 ($13,966)
  5. 4 Open-market sale Sr. VP, Drug Development sold 18,270 shares at $5.23 ($95,552)
  6. 5 Insider Annual Insider Trading Report
  7. 4 Grant or award Sr. VP, Business & Comm. Dvp. acquired 25,000 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Director acquired 1,440,923 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy Director bought 24,264 shares at $3.64 ($88,411)
  13. 4 Open-market buy Director bought 75,736 shares at an average $3.64 ($275,505)
  14. 4 Open-market buy SVP, Chief Medical Officer bought 3,514 shares at an average $2.93 ($10,288)
  15. 4 Open-market sale Sr. VP, Chief Comm. Officer sold 4,000 shares at $3.21 ($12,840)
  16. 4 Grant or award Director acquired 7,722 shares (grant or award)
  17. 4 Grant or award Director acquired 3,861 shares (grant or award)
  18. 4 Grant or award Director acquired 15,444 shares (grant or award)
  19. 4 Grant or award Director acquired 15,444 shares (grant or award)
  20. 4 Open-market buy Director bought 67,541 shares at an average $3.90 ($263,208)

Page 23 of 29 · 564 filings